• Journal of Sasang Constitutional Medicine
• /
• v.13 no.2
• /
• pp.62-73
• /
• 2001

1. Purpose 'Gu-Bon' of ${\ulcorner}$Soose Bowon${\lrcorner}$ found lately was written in 1940, through comparing with 'Gu-Bon' and 'In-Bon'. In 'Gu-Bon' and 'In-Bon', there are many different contents. The aim of the present study was to find changes of Dong-Mu's recognition on Symptom of Soeumin's Disease and Soyangin's Disease from 1894 to 1900 2. Methods Comparing with 'Gu-Bon' and 'In-Bon' on Symptom of Soeumin's Disease and Soyangin's Disease, Mechanism . region . main symptom and treatment of Soeumin's Disease and Soyangin's Disease are arranged. and changes of Dong-Mu's recognition on Symptom of Soeumin's Disease and Soyangin's Disease from 1894 to 1900 was found 3. Results 1) In 'Gu-Bon' of ${\ulcorner}$Soose Bowon${\lrcorner}$, Dong-mu recognized Symptom of Soeumin's Disease and Soyangin's Disease, mainly through the conception of 'ventral-dorsal--interior-exterior' and 'Main Qi of life protection' 2) In 'In-Bon' of ${\ulcorner}$Soose Bowon${\lrcorner}$, Dong-mu recognized Symptom of Soeumin's Disease and Soyangin's Disease, mainly through the conception of 'ventral-dorsal-interior-exterior' and 'Ascending of Yang-Qi and Descending of Yin-Qi' 3) In 'Gu-Bon' of ${\ulcorner}$Soose Bowon${\lrcorner}$, Symptom of Soeumin's Disease was classified into 'Taeyang Disease' and 'Yang-myoung Disease'. But In 'In-Bon' of ${\ulcorner}$Soose Bowon${\lrcorner}$, Symptom of Soeumin's Disease was classified into 'Mang-yang' and 'Ul-guang'

• Investigative Magnetic Resonance Imaging
• /
• v.21 no.4
• /
• pp.273-275
• /
• 2017

Thiemann's disease is a form of idiopathic avascular necrosis of the immature epiphyses of the phalanges of the fingers and toes. Few cases of Thiemann's disease have been reported because the disease is rare and difficult to diagnose. To the best of our knowledge, magnetic resonance imaging (MRI) findings of Thiemann's disease have not been reported. Here, we report a case of Thiemann's disease diagnosed by typical clinical symptoms and characteristic MRI findings before radiologic bony abnormalities were apparent.

• Journal of Yeungnam Medical Science
• /
• v.24 no.1
• /
• pp.11-23
• /
• 2007

Hirschsprung's disease is one of the most common causes of intestinal obstruction in neonates and infants. The underlying pathology of this disease is the absence of the ganglion cells in both the myenteric (Auerbach's) plexus and the submucosal (Meissner's) plexus. Since Hirschsprung's report in 1886, there have been thousands of papers on Hirschsprung's disease but the cause of the absence of the ganglion cells has not been identified. Hirschsprung's disease can be successfully treated with the Swenson, the Duhamel, and the Soave operations even though the pathogenesis is unknown. With the recent progress of molecular biology and genetics, a more detailed approach to the pathogenesis of Hirschsprung's disease can be undertaken. In addition, there have been recent developments in the surgical approach. In this review, recent advances in surgery for Hirschsprung's disease are presented.

• CELLMED
• /
• v.14 no.1
• /
• pp.64.1-64.5
• /
• 2024

Objective: A case study on improvement of Meniere's Disease through Ortho-Cellular Nutrition Therapy (OCNT). Methods: A Korean female in her 40s was incapable of daily living activities due to severe Ménière's Disease symptoms. OCNT was applied and the degree of symptoms was tracked. Results: Symptoms of Ménière's disease including headache and dizziness were improved after administering OCNT over approximately 4 months. Conclusion: Administering OCNT may help alleviate symptoms of patients suffering difficulty in daily life due to Ménière's Disease.

• Journal of Oriental Neuropsychiatry
• /
• v.20 no.3
• /
• pp.283-295
• /
• 2009

Objectives : Parkinson's disease is a chronic neuron-degenerative disease. The medication of dopamine, one of the most common treatment for the disease, has effects of improving the symptom, but when taken for a long term, the medicine brings about side-effects such as the phenomenon of medicinal efficacy disappearance and dyskinesia. In addition, it doesn't have any effects in slowing down or stopping the development of Parkinson's disease. Methods : Accordingly, this study aims to investigate the clinical cases to stop or improve the development of Parkinson's disease by carrying out an independent treatment with Oriental medicine and a combined treatment with Western and Oriental medicines respectively for over 6 months. Results and Conclusions : The results of the study is expected to be an important precedent for the treatment of neuron-degenerative diseases of cranial nerve including Parkinson's disease in the future.

• International Journal of Advanced Culture Technology
• /
• v.11 no.3
• /
• pp.9-17
• /
• 2023

Parkinson's disease is a complex neurodegenerative disease characterized by the progressive loss of dopamine-producing neurons in the substantia nigra, resulting in a variety of motor and non-motor symptoms. This study aimed to provide a comprehensive overview of Parkinson's disease, including classification of Parkinson's disease, impairment due to impairment, how disability is assessed, and how it is treated. Major symptoms of Parkinson's disease include tremors, stiffness, bradykinesia, and postural instability, and treatment methods include rehabilitation through drugs, surgical procedures, physical therapy, and occupational therapy. Early diagnosis, individualized treatment interventions, and comprehensive treatment involving a multidisciplinary medical team will be essential to manage Parkinson's disease and improve patients' quality of life. In conclusion, this study will provide comprehensive information on the complex nature of Parkinson's disease and serve as a useful guide for healthcare providers designing treatment plans for Parkinson's patients.

• The Journal of Korean Medicine Ophthalmology and Otolaryngology and Dermatology
• /
• v.30 no.3
• /
• pp.103-118
• /
• 2017

Objectives : The purpose of this study is to analyze recent research trend on pathology of Meniere's Disease and review the results in Korean Medicine. Methods : We searched MEDLINE on the title "Meniere's Disease" and "pathology" in recent 5 years and searched OASIS with KISS on the title "Meniere's Disease". Results : We found 21 studies on MEDLINE, 9 studies on OASIS and KISS about Meniere's Disease. The results are as follow. 1. In western medicine, the pathology of Meniere's disease is supposed to be related with endolymphatic hydrops and autoimmunity. The causes of endolymphatic hydrops are studied in various viewpoints such as disorder of endolymph drainage and homeostasis abnormality of endolymph. And autoimmunity is assumed to be associated with genetic factor. 2. In Korean medicine, Meniere's disease were mainly treated with acupuncture and hebal medicine. Conclusions : Korean medicinal approaches on pathology of Meneire's disease can be significant in view of endolymphatic hydrops. And on the basis of those outcomes, much more studies have to be researched for Korean medicinal treatment of Meneire's disease.

• Journal of Digital Convergence
• /
• v.19 no.12
• /
• pp.353-358
• /
• 2021

Parkinson's disease is the second most common degenerative brain disease after Alzheimer's in old age. Symptoms of Parkinson's disease are factors that reduce the quality of life in daily life, such as shaking hands, slowing behavior and cognitive function. Parkinson's disease that can slow the progression of the disease through early diagnosis. To diagnoze Parkinson's disease early, an algorithm was implemented to extract features using wav2vec and to diagnose the presence or absence of Parkinson's disease with deep learning(ANN). As a results of the experiment, the accuracy was 97.47%. It was better than the results of diagnosing Parkinson's disease using the existing neural network. The audio voice file could simply reduce the experiment process and obtain improved results.

• The Journal of Korean Physical Therapy
• /
• v.28 no.4
• /
• pp.227-231
• /
• 2016

Purpose: This study was conducted to explore the effects of aerobic exercise on the severity of disease and walking ability in patients with Parkinson's disease. Methods: Twelve patients with Parkinson's disease participated in the study. Participants were randomly assigned to either an aerobic exercise group (n=6) or a self-exercise group (n=6). All participants underwent treadmill training for 30 minutes. In addition, the experimental group (aerobic exercise group) and control group (self-exercise group) participated in a 30 minutes exercise program. In both groups, exercise was performed five times a week for four weeks. Outcome including disease severity (Unified Parkinson's Disease Rating Scale) and walking ability (10 m walking speed test, 6 minutes walking test, timed up-and-go test) were measured at baseline and after 4-weeks. Results: Significant differences in disease severity and walking ability were observed between the pre- and post-exercise groups (p<0.05). The improvement of disease severity and walking endurance was significantly higher in the experimental group than in the control group (p<0.05). Conclusion: These findings demonstrate that aerobic exercise is effective at improving disease severity and walking endurance in patients with Parkinson's disease.

• Gut and Liver
• /
• v.12 no.6
• /
• pp.623-632
• /
• 2018

Intestinal Behçet's disease is a rare, immune-mediated chronic intestinal inflammatory disease; therefore, clinical trials to optimize the management and treatment of patients are scarce. Moreover, intestinal Behçet's disease is difficult to treat and often requires surgery because of the failure of conventional medical treatment. Administration of anti-tumor necrosis factor-${\alpha}$, a potential therapeutic strategy, is currently under active clinical investigation, and evidence of its effectiveness for both intestinal Behçet's disease and inflammatory bowel diseases has been accumulating. Here, we review updated data on current experiences and outcomes after the administration of anti-tumor necrosis factor-${\alpha}$ for the treatment of intestinal Behçet's disease. In addition to infliximab and adalimumab, which are the most commonly used agents, we describe agents such as golimumab, etanercept, and certolizumab pegol, which have recently been shown to be effective in refractory intestinal Behçet's disease. This review also discusses safety issues associated with anti-tumor necrosis factor-${\alpha}$, including vulnerability to infections and malignancy.